Ei­sai launch­es biotech di­vi­sion in Mass­a­chu­setts aimed at Alzheimer’s, I/O and au­toim­mune dis­eases

Ei­sai is tack­ling Alzheimer’s, au­toim­mune dis­eases and the tu­mor mi­croen­vi­ron­ment with a new “biotech-like” re­search unit in An­dover, MA that has al­ready brought to­geth­er 90 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER